Cite
Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy.
MLA
Li, Xinxin, et al. “Dual Target PARP1/EZH2 Inhibitors Inducing Excessive Autophagy and Producing Synthetic Lethality for Triple-Negative Breast Cancer Therapy.” European Journal of Medicinal Chemistry, vol. 265, Feb. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.116054.
APA
Li, X., Wang, C., Li, S., Yin, F., Luo, H., Zhang, Y., Luo, Z., Chen, Y., Wan, S., Kong, L., & Wang, X. (2024). Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy. European Journal of Medicinal Chemistry, 265, N.PAG. https://doi.org/10.1016/j.ejmech.2023.116054
Chicago
Li, Xinxin, Cheng Wang, Shang Li, Fucheng Yin, Heng Luo, Yonglei Zhang, Zhongwen Luo, et al. 2024. “Dual Target PARP1/EZH2 Inhibitors Inducing Excessive Autophagy and Producing Synthetic Lethality for Triple-Negative Breast Cancer Therapy.” European Journal of Medicinal Chemistry 265 (February): N.PAG. doi:10.1016/j.ejmech.2023.116054.